View in EDS HTML Full Text PDF Full Text

JAK2V617F drives gut microbiota differences in patients with myeloproliferative neoplasms.

Saved in:
Bibliographic Details
Title: JAK2V617F drives gut microbiota differences in patients with myeloproliferative neoplasms.
Authors: Eickhardt‐Dalbøge, Christina Schjellerup1,2,3 (AUTHOR) chsd@regionsjaelland.dk, Nielsen, Henrik V.3 (AUTHOR), Fuursted, Kurt3 (AUTHOR), Stensvold, Christen Rune3 (AUTHOR), Andersen, Lee O' Brien3 (AUTHOR), Lilje, Berit3 (AUTHOR), Larsen, Morten Kranker2,4 (AUTHOR), Kjær, Lasse2 (AUTHOR), Christensen, Sarah Friis2 (AUTHOR), Knudsen, Trine Alma2 (AUTHOR), Skov, Vibe2 (AUTHOR), Sørensen, Anders Lindholm2 (AUTHOR), Ellervik, Christina4,5,6 (AUTHOR), Olsen, Lars Rønn7 (AUTHOR), Christensen, Jens Jørgen Elmer1,8 (AUTHOR), Nielsen, Xiaohui Chen1 (AUTHOR), Hasselbalch, Hans Carl2,4 (AUTHOR), Ingham, Anna Cäcilia3 (AUTHOR)
Source: European Journal of Haematology. May2024, Vol. 112 Issue 5, p776-787. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:09024441
DOI:10.1111/ejh.14169